Glucocorticoid inhibits lung cancer cells proliferation and migration by suppressing smad2/3 activation
Abstract Glucocorticoid (GCs), as an adjuvant drug, is widely used for alleviating chemotherapy or immunotherapy-induced adverse events, such as nausea and immune-related diseases in lung cancer treatment. However, whether GCs directly affects lung cancer progression remains unclear. This study focu...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Portfolio
2025-12-01
|
| Colección: | Scientific Reports |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1038/s41598-025-29163-3 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|